Trial · NCT04550936
Trial comparisons17
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
1 to 17 of 17
Download this page as JSON| Comparison | Source |
|---|---|
| Invasive Aspergillosis vs Mucormycosis: Number of Participants With Adverse Event at Week 24 | Trial comparisons |
| Invasive Aspergillosis vs Mucormycosis: Number of Participants With Inpatient Hospitalization | Trial comparisons |
| Invasive Aspergillosis vs Mucormycosis: Number of Participants With Adverse Event at Week 12 | Trial comparisons |
| Invasive Aspergillosis vs Mucormycosis: Number of Participants With Isavuconazole Administered as Part of Combination Therapy | Trial comparisons |
| Invasive Aspergillosis vs Mucormycosis: All-Cause Mortality at Week 6 | Trial comparisons |
| Invasive Aspergillosis vs Mucormycosis: Number of Participants With Serious Adverse Event at Week 12 | Trial comparisons |
| Invasive Aspergillosis vs Mucormycosis: Number of Participants Who Switched to New Antifungal | Trial comparisons |
| Invasive Aspergillosis vs Mucormycosis: Number of Participants With Adverse Event at Week 6 | Trial comparisons |
| Invasive Aspergillosis vs Mucormycosis: Number of Participants With Any Outpatient Visits | Trial comparisons |
| Invasive Aspergillosis vs Mucormycosis: Number of Participants With Serious Adverse Event at Week 6 | Trial comparisons |
| Invasive Aspergillosis vs Mucormycosis: Number of Participants With Isavuconazole Treatment Modification | Trial comparisons |
| Invasive Aspergillosis vs Mucormycosis: All-Cause Mortality at Week 24 | Trial comparisons |
| Invasive Aspergillosis vs Mucormycosis: Number of Participants With Serious Adverse Event at Week 24 | Trial comparisons |
| Invasive Aspergillosis vs Mucormycosis: deaths from any cause | Trial comparisons |
| Invasive Aspergillosis vs Mucormycosis: Number of Participants With Therapeutic Drug Monitoring (TDM) | Trial comparisons |
| Invasive Aspergillosis vs Mucormycosis: All-Cause Mortality at Week 12 | Trial comparisons |
| Invasive Aspergillosis vs Mucormycosis: serious adverse events | Trial comparisons |
trials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04550936/comparisons